At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
RXST RxSIGHT, INC.
Post-Market Trading 12-18 19:48:49 EST
37.20
-0.84
-2.21%
盘后36.40
-0.80-2.15%
18:09 EST
High38.40
Low36.70
Vol640.84K
Open38.25
D1 Closing38.04
Amplitude4.47%
Mkt Cap1.50B
Tradable Cap1.28B
Total Shares40.30M
T/O23.97M
T/O Rate1.86%
Tradable Shares34.39M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Wells Fargo Downgrades RxSight to Equal Weight From Overweight, $56 Price Target
RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.